Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Athera Biotechnologies AB
AB
In liquidation
Org 5566206859
Other research and experimental development on natural sciences and engineering
·
NACE 7219
Est. 2002 · 24 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Other research and experimental development on natural sciences and engineering
/
Athera Biotechnologies AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2016: 0M
0M
2016
2017: 0M
0M
2017
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 0M
0M
2020
EBITDA
SEK millions
0M
-13M
-26M
-38M
-51M
2016: -15M
-15M
2016
2017: -41M (-173% vs 2016)
-41M
-173%
2017
2018: -22M (+46% vs 2017)
-22M
+46%
2018
2019: -28M (-27% vs 2018)
-28M
-27%
2019
2020: -28M (0% vs 2019)
-28M
0%
2020
Income statement
SEK thousands
Item
2020
2019
2018
2017
2016
Revenue
0
0
114
0
0
Staff expenses
—
—
—
—
—
EBITDA
−27 555
−28 404
−21 765
−41 065
−15 153
Depreciation & amort.
−0
−0
−0
−0
−1 629
EBIT
−27 555
−28 404
−21 765
−41 065
−16 782
Net financials
54
61
50
40
1
Profit before tax
−27 501
−28 343
−21 715
−41 025
−16 781
Tax
−0
−0
−0
−0
−0
Net profit
−27 501
−28 343
−21 715
−41 025
−16 781
Balance sheet
SEK thousands
Item
2020
2019
2018
2017
2016
Total assets
15 109
36 110
9 495
31 693
15 625
Equity
12 934
30 435
4 385
26 100
9 850
Long-term debt
0
0
0
0
0
Short-term debt
2 175
5 675
5 111
5 593
5 776
Total debt
2 175
5 675
5 111
5 593
5 776
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2016
2020
Equity ratio
85,6 %
This company
38,2 %
Market median
This company
Market median
124% above market
2016
2020
Return on equity
−212,6 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2016
2020
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2016
2020
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2016
2020
Debt / equity
0,17×
This company
0,62×
Market median
This company
Market median
73% below market
2016
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
View
PDF
More on Athera Biotechnologies AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
